Fomepizole: Difference between revisions
(Created page) |
No edit summary |
||
| Line 52: | Line 52: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Toxicology]] | |||
Revision as of 17:36, 9 August 2018
Administration
- Type: Alcohol dehydrogenase inhibitor
- Routes of Administration: Intravenous
- Common Trade Names: Antizol
Adult Dosing
- Loading: 15 mg/kg
- Maintenance: 10 mg/kg every 12 hours
Pediatric Dosing
- Loading: 15 mg/kg
- Maintenance: 10 mg/kg every 12 hours
Special Populations
- Pregnancy Rating: C
- Lactation risk: Unknown if excreted in breast mild
Hemodialysis Dosing
For patients undergoing hemodialysis for complications associated with toxic alcohol ingestion, dosing should be adjusted in consultation with a nephrologist.
Hepatic Dosing
Fomepizole is metabolized in the liver, specific dosing adjustments for hepatic impairment have not been developed.
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Bradycardia
- Hypotension
- Shock
- Anemia
- Disseminated intravascular coagulation (DIC)
Common
- Headache
- Nausea
Pharmacology
- Half-life: Not calculated
- Metabolism: Hepatic
- Excretion: Urine
Mechanism of Action
Competitively inhibits alcohol dehydrogenase.
See Also
References
- Lexicomp
